Blog
Revolutionary Gut-on-Chip Tech: Transforming Biologic Drug Testing
🔍 Vivtex and Astellas team up to create oral biologic Gut-on-Chip tech, revolutionizing drug testing and therapy development. 💊🧪
Powerhouse Partnership Forms Europe’s Top Biologics CDMO
🔬💪 Biovian and 3P Biopharmaceuticals team up to form 3PBIOVIAN, a pan-European biologics CDMO with full development and manufacturing capabilities.
Game-Changing Merger Creates European CDMO Powerhouse
🔍 Biovian and 3P Biopharmaceuticals merge to create 3PBIOVIAN, a European CDMO offering end-to-end services. 🌍👥🔬🧫🧬💪
Bioprocess Vendors Predict Recovery in 2024: Here’s How
📢 Bioprocess vendors expect a recovery in 2024, despite normalization dragging on. 🧪💧🏭🔬💼
Biologic Supply Chains: A National Security Threat?
🌍 Biologic supply chains can impact national security, as shown during the Ukraine war and Covid pandemic. 💉
Regeneron Joins Forces with 2seventy for Breakthrough Cancer Treatments
Regeneron partners with 2seventy to boost cell therapy pipeline 🤝💼. Aims to develop immune cell therapies for cancer treatment 🧪🔍.
Biogen Pulls Plug on Controversial Alzheimer’s Drug
📢 Biogen discontinues controversial Alzheimer's drug Aduhelm amid mounting criticism and lack of evidence. 💊❌👥
Pfizer’s Bold Investment in Cancer Therapies
📢 Pfizer applauds its big bet in ADCs, a promising cancer treatment area, expecting long-term payoffs and therapeutic advancements. 💪🏥🩺
Cellibre Joins BioMADE: Revolutionizing Sustainable Biomanufacturing
🌱 San Diego-based company Cellibre joins BioMADE for sustainable manufacturing and biomanufacturing innovation. 💰 The White House funds $2 billion for biotechnology. 🤝 Collaboration for lower prices, job creation, and carbon reduction in the US.
Biomanufacturing Goes Green: A Sustainable Revolution
🌿 Biomanufacturing aims for net-zero emissions by 2050, using renewable energy, reducing carbon footprint, and promoting recycling. 🌍🔬⚡🛢️💡
